Switch to: References

Add citations

You must login to add citations.
  1. The Normative Power of Consent and Limits on Research Risks.Aaron Eli Segal & David S. Wendler - 2024 - Ethical Theory and Moral Practice 27 (4).
    Research regulations around the world do not impose any limits on the risks to which consenting adults may be exposed. Nonetheless, most review committees regard some risks as too high, even for consenting adults. To justify this practice, commentators have appealed to a range of considerations which are external to informed consent and the risks themselves. Most prominently, some argue that exposing consenting adults to very high risks has the potential to undermine public trust in research. This justification assumes that (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Context is Needed When Assessing Fair Subject Selection.G. Owen Schaefer - 2020 - American Journal of Bioethics 20 (2):20-22.
    Volume 20, Issue 2, February 2020, Page 20-22.
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Risk Limits in Fair Subject Selection.Robert Steel - 2020 - American Journal of Bioethics 20 (2):30-32.
    Volume 20, Issue 2, February 2020, Page 30-32.
    Download  
     
    Export citation  
     
    Bookmark  
  • Somewhere between dystopia and utopia.Jesse Wall - 2020 - Journal of Medical Ethics 46 (3):161-162.
    The Journal of Medical Ethics can sometimes read part Men Like Gods and part A Brave New World. At times, we learn how all controversies can resolved with reference to four principles. At other times, we learn how “every discovery in pure science is potentially subversive”.1 This issue is no exception. Here, we can read about the utopia of gene editing, manufactured organs, and machine learnt algorithmic decision-making. We can also read about the dystopia of inherited disorders from edited germlines, (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Ethics of HIV cure research: an unfinished agenda. [REVIEW]Jeremy Sugarman, John A. Sauceda, Brandon Brown, Parya Saberi, Mallory O. Johnson, Laney Henley, Samuel Ndukwe, Hursch Patel, Morénike Giwa Onaiwu, Danielle M. Campbell, David Palm, Orbit Clanton, David Kelly, Jan Kosmyna, Michael Louella, Laurie Sylla, Christopher Roebuck, Nora Jones, Lynda Dee, Jeff Taylor, John Kanazawa & Karine Dubé - 2021 - BMC Medical Ethics 22 (1):1-14.
    BackgroundThe pursuit of a cure for HIV is a high priority for researchers, funding agencies, governments and people living with HIV (PLWH). To date, over 250 biomedical studies worldwide are or have been related to discovering a safe, effective, and scalable HIV cure, most of which are early translational research and experimental medicine. As HIV cure research increases, it is critical to identify and address the ethical challenges posed by this research.MethodsWe conducted a scoping review of the growing HIV cure (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Is There an Ethical Upper Limit on Risks to Study Participants?Nir Eyal - 2020 - Public Health Ethics 13 (2):143-156.
    Are some risks to study participants too much, no matter how valuable the study is for society? This article answers in the negative.
    Download  
     
    Export citation  
     
    Bookmark   2 citations